| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5602312 | European Journal of Vascular and Endovascular Surgery | 2017 | 4 Pages |
Abstract
Iloprost treatment decreases ADMA and SDMA, which are associated with endothelial dysfunctions in patients with Buerger's disease. Of note, the still higher than normal range of SDMA levels after iloprost treatment suggests that treatment should continue until SDMA levels are within the normal range in this patient population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
S. Senol, A. Senol,